GE HealthCare Technologies (NASDAQ:GEHC) Upgraded by Wall Street Zen to “Buy” Rating

GE HealthCare Technologies (NASDAQ:GEHC) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

GEHC has been the subject of several other research reports. The Goldman Sachs Group reaffirmed a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Stifel Nicolaus raised their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Barclays lifted their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $74.27 on Friday. The firm has a market cap of $33.85 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 1.69 and a beta of 1.03. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The stock has a 50-day moving average price of $81.81 and a 200-day moving average price of $78.54. GE HealthCare Technologies has a 1-year low of $57.65 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of the company. Reflection Asset Management bought a new stake in GE HealthCare Technologies in the 4th quarter worth about $36,000. Strategic Investment Solutions Inc. IL increased its position in shares of GE HealthCare Technologies by 404.0% during the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,255 shares of the company’s stock valued at $103,000 after acquiring an additional 1,006 shares during the last quarter. MidFirst Bank purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $35,000. MV Capital Management Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter worth $33,000. Finally, Compound Planning Inc. boosted its position in GE HealthCare Technologies by 22.6% in the fourth quarter. Compound Planning Inc. now owns 3,299 shares of the company’s stock worth $271,000 after purchasing an additional 609 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.